Co-funding Institute(s):
National Cancer Institute (NCI)
Translational Genomics of Neuroblastoma (TGiN) Year 3
, October 2009
Bethesda North Marriott and Conference Center, Bethesda, MD, United States
Contact for additional information: Dr. Javed Khan, NCI 301-480-0314
DescriptionGoals of this conference are to (1) identify novel validated biomarkers for predicting prognosis, (2) identify and discuss novel targets, (3) update technology, (4) update collaborative models, (5) design a future collaborative study, (6) generate a database and release data, and (7) discuss and confirm the funding mechanisms.
|